Parthenon Capital Announces Strategic Growth Investment in Medical Review Institute of America
Summary
The firm brings deep expertise in supporting high-growth healthcare businesses at the intersection of services and technology and will be an invaluable partner as we look to scale and innovate, said Ron Sullivan, CEO. We are grateful for Summit Partners active support over the last several years and for their continued partnership moving forward. We are excited to continue to provide best-in-class utilization management services to our clients while also looking for even more ways to add value in the years ahead.Dan Killeen, a Partner at Parthenon, said, MRIoA plays a critical role in enabling payer organizations to ensure members receive timely access to the care they need. With significant investments in clinical resources, service delivery and automation, the Company is uniquely positioned to help clients navigate a dynamic health care system, and we are excited to partner with MRIoA as it enters this next chapter of growth.Dave Ament, Co-CEO of Parthenon, added, MRIoA has established itself as a trusted, scale partner providing high-quality clinical review solutions to health plans, third-party administrators and pharmacy benefit managers across the country. For more information, visit www.mrioa.com.Parthenon Capital is a leading growth-oriented private equity firm with offices in Boston, San Francisco and Austin.